Clinical Trials
13 trialsNCT02012699 2026-05-05
iCaRe2
University of Nebraska
Recruiting
NCT05461430 2026-04-13
TraveraRTGx
Travera Inc
Completed
NCT03452774 2025-10-28
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Massive Bio, Inc.
Recruiting
NCT07161882 2025-09-16
SAFRO2202
Société Algérienne de Formation et de Recherche en Oncologie
Recruiting
NCT06937112 2025-04-22
18F Labeled FAP Targeted Molecular Probe in Early Tumor Diagnosis
Nanjing First Hospital, Nanjing Medical University
Recruiting
NCT04028479 2024-12-18
ROOT
Taproot Health
Completed
NCT04985357 2024-11-25
Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to Drugs
Travera Inc
Withdrawn
NCT06081270 2023-10-13
MUT-ONC
University of Milano Bicocca
Unknown
NCT02948946 2021-08-04
Clinical Utility Assay as a Biomarker for Gastroenteropancreatic and Lung Neuroendocrine Tumors
H. Lee Moffitt Cancer Center and Research Institute
Completed
NCT03896958 2020-12-04
PIONEER
SpeciCare
Unknown
NCT01135849 2015-11-17
B-Receptor Signaling in Cardiomyopathy
Stanford University
Completed
NCT00454376 2013-10-29
Disease-Specific Questionnaire in Assessing Quality of Life in Patients With Gastrointestinal-Related Neuroendocrine Tumors
National Cancer Institute (NCI)
Unknown
NCT00687778 2008-06-02
11C-Acetate PET/CT Non-FDG-Avid Tumors
Tel-Aviv Sourasky Medical Center
Unknown